📣 Listen to international experts treating real-world cases and get real insights based on the #ESMOGuidelines applicable to your daily practice.

Access with your ESMO account: 🔗ow.ly/B5zQ50S3LON

Nadia Harbeck,MD PhD Rodrigo Sánchez-Bayona Alessandra Gennari MD PhD Andri Papakonstantinou

#ESMO24 : A wealth of new data in oncology awaits you in Barcelona. This year, submitted abstracts grew by almost 📈10%.

➡️ Register by 12 June to get the early rate: 🔗ow.ly/stRx50RWCKR

👉 View the resources for this thought-provoking discussion of three recent, important publications on #breastcancer #NSCLC and urothelial #cancer .

Access now with your ESMO membership: 🔗ow.ly/6QLm50RYHsQ

Evandro de Azambuja, MD, PhD Benjamin Besse Patrizia Giannatempo

📣 Call for abstracts: Connect with top oncologists, researchers, and industry leaders at #ESMOASIA24 .

Explore groundbreaking cancer research and innovative treatments. Don't miss the chance to play an active role in it.

Submission deadline: 16 July: ow.ly/qmMI50RWGcu

#ESMOMembers 📢 Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now.

👉ow.ly/fHX850RWt5T

ESMO has just released recommendations for the use of next-generation sequencing (NGS) for patients with #AdvancedCancer which represent an expansion of the ones published in 2020. Read #ESMODailyReporter to learn more
📌ow.ly/XuNf50RXIKS

Today is the last day to apply for the European Society for Medical Oncology travel grants to support patient advocates attending the #ESMOCongress 2024 Patient Advocacy Track in #Barcelona from September 13th to 17th, 2024.
More information here: esmo.org/meeting-calend…

‘Best way to share knowledge in a rapidly-evolving field’, ‘Useful to improve patient care’, ‘Accurate & concise information’: @martatapia1, Javier Cortes MD PhD, Laura Moliner & P. Rutkowski,on why they contribute to and/or read #ESMOBooks 🔗ow.ly/CJzk50RU63l

Ivana Božović

There is still time to join this expert exchange and share knowledge with the experts in metastatic #breastcancer .

Register now and join the conversation: 🔗ow.ly/bcZJ50RIwVU

The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find out more about the candidates.
📌 ow.ly/4Uku50RSIJL

Super #ESMOYOC meeting to plan future exciting activities for ESMO - Eur. Oncology young members: so privileged to work with such brilliant minds ❤️Maria Kfoury Pablo Mando Rille Rodrigo Sánchez-Bayona Elene Mariamidze Myrto K. Moutafi Liz Connolly Pawel Sobczuk Hongcheng Zhu 祝鸿程 Deniz Can Guven Emre Kocakavuk, MD, PhD

Some of the many highlights of #ESMOBreast24
🗝️DOLAF trial and its interesting hypothesis of combining PARPi and ET and IO
🗝️ T-DXd retreatment safety after G1 ILD
🗝️ Growth in data of fertility related topics in young BRCA patients
🗝️ Sexual health in the center of the stage

#ESMOBreast24 #ESMOAmbassadors
🔑🚫Primary outcome in IMpassion132 highlights unmet need for early relapsing #TNBC
🔑Emerging data from ADC-IO combinations
🔑Safety and #QoL updates for new 💊capivasertib and 💉datopotamab
🔑📈Body of evidence for new biomarkers 🎯such as HER2Dx

#ESMOBreast24 : Atezolizumab + sacituzumab govitecan show encouraging activity in inoperable #TNBC . Efficacy & safety of the first-line novel combination were assessed in patients w/ untreated PD-L1 positive locally advanced or metastatic tumours.
👉 ow.ly/AFI750RQJuJ

Early recurrent TNBC represents a major unmet need in breast oncology, with unfortunately no added benefit from PD-L1 inhibition added to chemotherapy.

Novel ADCs are being evaluated in this population, with great hopes for improved outcomes.

#ESMOBreast24 #ESMOAmbassadors

Important data at #ESMOBreast14 in #survivorship field including safety of vaginal estrogen therapy for selected patients, physical exercise in advanced disease and fertility techniques in #BRCA carriers (personal COI here)…what a fantastic event!!!

ESMO - Eur. Oncology #ESMOAmbassadors

The clock is ticking…only 34 days left until we welcome you for the ESMO - Eur. Oncology Gastrointestinal Cancers Congress 2024 in beautiful Munich.

#ESMOGI24

This is going to be fun🤩

✅Two very interesting cases
🚀Two bright young colleagues presenting

and Myrto K. Moutafi running the show…what can go wrong?

Do not miss the chance to attend the upcoming YO4YO Clinical Case Discussion where Ben Westphalen, Myrto K. Moutafi, Erman Akkus and Paolo D’arienzo will discuss how to approach a genomic profiling report for choosing the next line of therapy.
📌ow.ly/BoLO50RP7H1